Valuation: Highnoon Laboratories Limited

Market Cap 49.43B 179M 157M 149M 134M 253M 17.12B 257M 1.78B 686M 8.75B 670M 656M 28.05B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 49.43B 179M 157M 149M 134M 253M 17.12B 257M 1.78B 686M 8.75B 670M 656M 28.05B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.45x
Free-Float
50.02%
Yield 2026 *
4.82%
Yield 2027 * 5.57%
1 day-1.08%
1 week-2.73%
1 month-0.20%
3 months-6.95%
6 months+8.67%
Current year-8.75%
1 week 930
Extreme 930
959
1 month 904.01
Extreme 904.01
965
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 365
Extreme 365
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2012-09-06
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%-2.73%-21.02%+145.58% 180M
-2.33%+0.53%+51.65%+115.42% 1,056B
-1.06%-1.65%+42.78%+69.98% 645B
-0.65%-1.32%+12.98%+75.49% 465B
-2.66%-1.87%+73.13%+41.15% 368B
-0.06%-3.88%+34.32%+39.39% 335B
-0.79%+2.01%+19.82%+27.79% 275B
-1.19%-1.21%+9.82%+10.61% 255B
-0.50%+3.80%+49.37%+56.84% 229B
-1.47%-1.53%+34.28%+98.89% 188B
Average -0.87%-0.37%+30.71%+68.11% 381.6B
Weighted average by Cap. -1.02%-0.23%+39.91%+71.39%

Financials

2026 *2027 *
Net sales 30.4B 110M 96.66M 91.58M 82.68M 156M 10.52B 158M 1.1B 422M 5.38B 412M 403M 17.25B 34.16B 123M 109M 103M 92.92M 175M 11.83B 177M 1.23B 474M 6.05B 463M 453M 19.39B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-09-30 PKR 933.00 -1.08% 8,722
26-09-29 PKR 943.22 -0.52% 5,900
26-09-28 PKR 948.13 -0.36% 1,800
26-09-25 PKR 951.59 -0.07% 4,382
26-09-24 PKR 952.25 -0.73% 3,336
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
933.00PKR
Average target price
1,121.00PKR
Spread / Average Target
+20.15%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock